Organogenesis Financial Statements 2016-2025 | ORGO

Revenue

$482.043

$433.14

$450.893

$467.359

$338.298

$260.981

$193.449

$198.508

$138.732

Cost Of Goods Sold

$115.741

$106.481

$105.019

$114.199

$87.319

$75.948

$68.808

$61.22

$48.201

Gross Profit

$366.302

$326.659

$345.874

$353.16

$250.979

$185.033

$124.641

$137.288

$90.531

Research And Development Expenses

$50.271

$44.38

$39.762

$30.742

$20.086

$14.799

$10.742

$9.065

$6.277

SG&A Expenses

$294.513

$269.754

$283.808

$250.2

$204.193

$200.088

$161.961

$133.717

$93.029

Other Operating Income Or Expenses

$-22.801

$-3.494

Operating Expenses

$367.585

$314.134

$323.57

$280.942

$224.279

$214.887

$176.197

$142.782

$99.306

Operating Income

$-1.283

$12.525

$22.304

$72.218

$26.7

$-29.854

$-51.556

$-5.494

$-8.775

Total Non-Operating Income/Expense

$-1.524

$-2.133

$-2.022

$-9.132

$-8.936

$-8.705

$-13.191

$-9.056

$-5.926

Pre-Tax Income

$-2.807

$10.392

$20.282

$63.086

$17.764

$-38.559

$-64.747

$-14.55

$-14.701

Income Taxes

$-3.668

$5.447

$4.75

$-31.116

$0.53

$0.15

$0.084

$-7.025

$0.065

Income After Taxes

$0.861

$4.945

$15.532

$94.202

$17.234

$-38.709

$-64.831

$-7.525

$-14.766

Other Income

Income From Continuous Operations

$0.861

$4.945

$15.532

$94.202

$17.234

$-38.709

$-64.831

$-7.525

$-14.766

Income From Discontinued Operations

Net Income

$-0.937

$4.945

$15.532

$94.202

$17.234

$-39.277

$-64.831

$-8.811

$-16.987

EBITDA

$24.091

$35.974

$40.335

$88.894

$34.883

$-20.028

$-44.578

$0.134

$-1.456

EBIT

$-1.283

$12.525

$22.304

$72.218

$26.7

$-29.854

$-51.556

$-5.494

$-8.775

Basic Shares Outstanding

132

131

130

128

108

Shares Outstanding

132

133

132

134

111

Basic EPS

$-0.01

$0.04

$0.12

$0.73

$0.16

$-0.42

$-0.94

$-0.14

$-0.27

EPS - Earnings Per Share

$-0.01

$0.04

$0.12

$0.70

$0.15

$-0.42

$-0.94

$-0.14

$-0.27